propafenone has been researched along with Ebstein Anomaly in 1 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
Ebstein Anomaly: A congenital heart defect characterized by downward or apical displacement of the TRICUSPID VALVE, usually with the septal and posterior leaflets being attached to the wall of the RIGHT VENTRICLE. It is characterized by a huge RIGHT ATRIUM and a small and less effective right ventricle.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pavoni, D | 1 |
| Ragazzo, S | 1 |
| Driussi, M | 1 |
| Antonini-Canterin, F | 1 |
| Pavan, D | 1 |
| Zardo, F | 1 |
| Nicolosi, GL | 1 |
1 other study available for propafenone and Ebstein Anomaly
| Article | Year |
|---|---|
Transient platypnea-orthodeoxia-like syndrome induced by propafenone overdose in a young woman with Ebstein's anomaly.
Topics: Adult; Anti-Arrhythmia Agents; Cyanosis; Dose-Response Relationship, Drug; Ebstein Anomaly; Echocard | 2003 |